Document is current

Article History

Received: 3 May 2024

Accepted: 13 May 2025

First Online: 26 May 2025

Declarations

:

: This project was approved by the Northern Sydney Local Health District Human Research Ethics Committees (HREC/17/HAWKE/480) and conducted in accordance with the Standards for Reporting Qualitative Research []. This research conducted on humans and/or human data, or material adhered to the Helsinki Declaration [].

: Not applicable.

: IBH is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd which aims to transform mental health services through the use of innovative technologies.A/Prof Elizabeth Scott is Principal Research Fellow at the Brain and Mind Centre, The University of Sydney. She is Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, and a Consultant Psychiatrist. She was the Medical Director, Young Adult Mental Health Unit, St Vincent’s Hospital Darlinghurst until January 2021. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier, Janssen and Eli-Lilly pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. She was the National Coordinator of an antidepressant trial sponsored by Servier. No other competing interests were reported.